IP Library Granted Patent US 8,815,973
Granted Patent B2
US 8,815,973 · App. 12/200,918 · Granted Aug 26, 2014

Cement products and methods of making and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,815,973
App. No.
12/200,918
Granted
Aug 26, 2014
Kind
B2
Abstract

Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component. The first component comprises a polymerizable resin comprising ethylenic unsaturated double bond, a suitable glycidyl group and/or a suitable isocyanate group. The second component includes a compound comprising more than one type of amine selected from the group consisting of primary amine, secondary amines, tertiary amines and quaternary amines. Alternatively, the second component includes a compound comprising a suitable mercapto (SH—) group, a hindered amine or a dimethylthiotoluenediamine (DMTDA). Optionally, the cement product includes a filler and/or a bioactive component to promote bone formation.

Claims (36)

1. An orthopedic or dental cement product comprising:

a first component comprising bisphenol A diglycidyl ether 33-67% w/w, trimethylolpropane triacrylate 33-67% w/w, and, optionally, trimethylolpropane benzoate diacrylate 0-33% w/w; and

a second component-comprising a mixture of spermidine 33-100% w/w and, optionally, 2-methyl-1,5-pentamethylenediamine 0-67% w/w,

wherein the first component and second component are capable of reacting with each other in a polymerization reaction to produce an orthopedic or dental cement, and when the first component and second component are reacted together in a polymerization reaction at room temperature and allowed to set at about 37° C., the reaction does not exceed a maximum temperature of 60° C. for a period of one minute.

2. The product of claim 1 , wherein, when the polymerizable resin of the first component and the compound of the second component are reacted together, the time needed to achieve a dry-to-touch finish is about 30 minutes or less.

3. The product of claim 1 , wherein the product comprises a filler and the filler comprises a bioceramic, graphite, pyrolytic carbon, bone powder, demineralized bone powder, anorganic bone, dentin tooth enamel, aragonite, calcite, nacre, tricalcium phosphate (α-TCP, β-TCP), hydroxyapatite, carbon, collagen, tendon or ligament derived tissue, keratin, cellulose, hydroxyapatite, calcium phosphate, or a mixture thereof.

4. The product of claim 1 , wherein the product further comprises triethylenediamine, N,N-dimethyl-p-toluidine, 1,4-diazabicyclo[2.2.2]octane, or N,N,N′,N′-tetrakis (3-aminopropyl)-1,4-butanediamine.

5. The product of claim 1 , wherein the first component and the second component are each packaged in (i) a separate chamber of the same container or (ii) a separate container.

6. A resorbable orthopedic or dental cement product comprising:

a first component comprising sorbitol polyglycidyl ether, trimethylolpropane benzoate diacrylate, 1,4-butanediol, or a combination thereof; and

a second component comprising spermidine 20-100% w/w and, optionally, a second polyamine selected from the group consisting of 2-methyl-1,5-pentamethylenediamine, 2-ethyl-1,3-trimethylenediamine, and combinations thereof in an amount of 0-80% w/w;

and a filler,

wherein the cement product is a biocompatible and resorbable orthopedic cement product, and wherein the first component and second component are capable of reacting with each other in a polymerization reaction to produce an orthopedic or dental cement, and when the first component and second component are reacted together in a polymerization reaction at room temperature and allowed to set at about 37° C., the reaction does not exceed a maximum temperature of 60° C. for a period of one minute.

7. The product of claim 6 , wherein, when the polymerizable resin of the first component and the compound of the second component are reacted together, the time needed to achieve a dry-to-touch finish is about 30 minutes or less.

8. The product of claim 6 , wherein the product comprises a filler and the filler comprises a bioceramic, graphite, pyrolytic carbon, bone powder, demineralized bone powder, anorganic bone, dentin tooth enamel, aragonite, calcite, nacre, tricalcium phosphate (α-TCP, β-TCP), hydroxyapatite, carbon, collagen, tendon or ligament derived tissue, keratin, cellulose, hydroxyapatite, calcium phosphate, or a mixture thereof.

9. The product of claim 6 , wherein the product further comprises triethylenediamine, N,N-dimethyl-p-toluidine, 1,4-diazabicyclo[2.2.2]octane, or N,N,N′,N′-tetrakis (3-aminopropyl)-1,4-butanediamine.

10. The product of claim 6 , wherein the first component and the second component are each packaged in (i) a separate chamber of the same container or (ii) a separate container.

11. An orthopedic or dental cement product comprising:

a first component comprising an amount up to 40% w/w sorbitol polyglycidyl ether, up to 40% w/w pentaerythritol tetraacrylate, and up to 40% w/w 1,4-butanediol such that the combined weight percent of sorbitol polyglycidyl ether, pentaerythritol tetraacrylate, and 1,4-butanediol total 100% w/w;

a second component comprising spermidine 20-100% w/w and, optionally, a second polyamine compound selected from the group consisting of 2-methyl-1,5-pentamethylenediamine, 2-ethyl-1,3-trimethylenediamine, and combinations thereof in an amount of 0-80% w/w; and

a filler,

wherein the first component and second component are capable of reacting with each other in a polymerization reaction to produce an orthopedic or dental cement, and when the first component and second component are reacted together in a polymerization reaction at room temperature and allowed to set at about 37° C., the reaction does not exceed a maximum temperature of 60° C. for a period of one minute.

12. The product of claim 11 , wherein, when the polymerizable resin of the first component and the compound of the second component are reacted together, the time needed to achieve a dry-to-touch finish is about 30 minutes or less.

13. The product of claim 11 , wherein the product comprises a filler and the filler comprises a bioceramic, graphite, pyrolytic carbon, bone powder, demineralized bone powder, anorganic bone, dentin tooth enamel, aragonite, calcite, nacre, tricalcium phosphate (α-TCP, β-TCP), hydroxyapatite, carbon, collagen, tendon or ligament derived tissue, keratin, cellulose, hydroxyapatite, calcium phosphate, or a mixture thereof.

14. The product of claim 11 , wherein the product further comprises triethylenediamine, N,N-dimethyl-p-toluidine, 1,4-diazabicyclo[2.2.2]octane, or N,N,N′,N′-tetrakis (3-aminopropyl)-1,4-butanediamine.

15. The product of claim 11 , wherein the first component and the second component are each packaged in (i) a separate chamber of the same container or (ii) a separate container.

16. A resorbable orthopedic or dental cement product comprising:

a first component comprising pentaerythritol tetraacrylate; and

a second component comprises a second component comprising spermidine; and

a filler comprising one or more types of fillers selected from the group consisting of bioceramics, bone powder, demineralized bone powder, an organic bone mineral material, dentin tooth enamel, collagen, tendon, ligament-derived tissue, keratin, cellulose, calcium phosphate material, hydroxyapatite, and tricalcium phosphate, wherein each of the first component and the second component is a separate mixture that includes a portion of the filler,

wherein the cement product is a biocompatible and resorbable orthopedic cement product, and wherein the first component and second component are capable of reacting with each other in a polymerization reaction to produce an orthopedic or dental cement, and when the first component and second component are reacted together in a polymerization reaction at room temperature and allowed to set at about 37° C., the reaction does not exceed a maximum temperature of 60° C. for a period of one minute.

17. The product of claim 16 , wherein the first component further comprises trimethylolpropane benzoate diacrylate.

18. The product of claim 16 , wherein, when the polymerizable resin of the first component and the compound of the second component are reacted together, the time needed to achieve a dry-to-touch finish is about 30 minutes or less.

19. The product of claim 16 , wherein the product comprises a filler and the filler comprises a bioceramic, graphite, pyrolytic carbon, bone powder, demineralized bone powder, anorganic bone, dentin tooth enamel, aragonite, calcite, nacre, tricalcium phosphate (α-TCP, β-TCP), hydroxyapatite, carbon, collagen, tendon or ligament derived tissue, keratin, cellulose, hydroxyapatite, calcium phosphate, or a mixture thereof.

20. The product of claim 16 , wherein the product further comprises triethylenediamine, N,N-dimethyl-p-toluidine, 1,4-diazabicyclo[2.2.2]octane, or N,N,N′,N′-tetrakis (3-aminopropyl)-1,4-butanediamine.

21. The product of claim 16 , wherein the first component and the second component are each packaged in (i) a separate chamber of the same container or (ii) a separate container.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: PIONEER SURGICAL TECHNOLOGY, INC.
Reel/Frame 046320/0040 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →
SECURITY AGREEMENT Recorded Jul 29, 2013
From: PIONEER SURGICAL TECHNOLOGY, INC.
To: TD BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 030892/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2012
From: SCHLOSSBERG, BRIAN M.
To: PIONEER SURGICAL TECHNOLOGY, INC.
Reel/Frame 028876/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2010
From: LIN, JUCHUI RAY; AHN, EDWARD S.
To: PIONEER SURGICAL TECHNOLOGY, INC.
Reel/Frame 025321/0780 →